Lanzi R - Search Results

1

Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency.

Losa M, Scavini M, Gatti E, Rossini A, Madaschi S, Formenti I, Caumo A, Stidley CA, Lanzi R. Losa M, et al. Among authors: lanzi r. Thyroid. 2008 Dec;18(12):1249-54. doi: 10.1089/thy.2008.0266. Thyroid. 2008. PMID: 19012473

2

Predictors of bone responsiveness to growth hormone (GH) replacement in adult GH-deficient patients.

Rossini A, Lanzi R, Losa M, Sirtori M, Gatti E, Madaschi S, Molinari C, Villa I, Scavini M, Rubinacci A. Rossini A, et al. Among authors: lanzi r. Calcif Tissue Int. 2011 Apr;88(4):304-13. doi: 10.1007/s00223-010-9459-8. Epub 2011 Jan 21. Calcif Tissue Int. 2011. PMID: 21253713

3

Growth Hormone Therapy Does Not Increase the Risk of Craniopharyngioma and Nonfunctioning Pituitary Adenoma Recurrence.

Losa M, Castellino L, Pagnano A, Rossini A, Mortini P, Lanzi R. Losa M, et al. Among authors: lanzi r. J Clin Endocrinol Metab. 2020 May 1;105(5):dgaa089. doi: 10.1210/clinem/dgaa089. J Clin Endocrinol Metab. 2020. PMID: 32112101

4

Bone and body composition analyses by DXA in adults with GH deficiency: effects of long-term replacement therapy.

Rossini A, Lanzi R, Galeone C, Pelucchi C, Pennacchioni M, Perticone F, Sirtori M, Losa M, Rubinacci A. Rossini A, et al. Among authors: lanzi r. Endocrine. 2021 Dec;74(3):666-675. doi: 10.1007/s12020-021-02835-6. Epub 2021 Jul 30. Endocrine. 2021. PMID: 34331234

5

Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency.

Lanzi R, Previtali SC, Sansone V, Scavini M, Fortunato M, Gatti E, Meola G, Bosi E, Losa M. Lanzi R, et al. J Endocrinol Invest. 2007 Apr;30(4):341-5. doi: 10.1007/BF03346302. J Endocrinol Invest. 2007. PMID: 17556873 Free article.

6

Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem.

Losa M, Gatti E, Rossini A, Lanzi R. Losa M, et al. Among authors: lanzi r. J Endocrinol Invest. 2008 Sep;31(9 Suppl):75-8. J Endocrinol Invest. 2008. PMID: 19020392 Review.

7

GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults.

Lanzi R, Losa M, Villa I, Gatti E, Sirtori M, Dal Fiume C, Rubinacci A. Lanzi R, et al. Eur J Endocrinol. 2003 Feb;148(2):185-91. doi: 10.1530/eje.0.1480185. Eur J Endocrinol. 2003. PMID: 12590637

8

Effects of growth hormone treatment on arginine to asymmetric dimethylarginine ratio and endothelial function in patients with growth hormone deficiency.

Setola E, Monti LD, Lanzi R, Lucotti P, Losa M, Gatti E, Galluccio E, Oldani M, Fermo I, Giovannelli M, Bosi E, Piatti P. Setola E, et al. Among authors: lanzi r. Metabolism. 2008 Dec;57(12):1685-90. doi: 10.1016/j.metabol.2008.07.024. Metabolism. 2008. PMID: 19013291 Clinical Trial.

9

Treatment of thyroid-associated orbitopathy with rituximab--a novel therapy for an old disease: case report and literature review.

Madaschi S, Rossini A, Formenti I, Lampasona V, Marzoli SB, Cammarata G, Politi LS, Martinelli V, Bazzigaluppi E, Scavini M, Bosi E, Lanzi R. Madaschi S, et al. Among authors: lanzi r. Endocr Pract. 2010 Jul-Aug;16(4):677-85. doi: 10.4158/EP09385.RA. Endocr Pract. 2010. PMID: 20350915

10

Time course of hypothalamic-pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors.

Madaschi S, Fiorino C, Losa M, Lanzi R, Mazza E, Motta M, Perna L, Brioschi E, Scavini M, Reni M. Madaschi S, et al. Among authors: lanzi r. Radiother Oncol. 2011 Apr;99(1):23-8. doi: 10.1016/j.radonc.2011.02.015. Epub 2011 Mar 30. Radiother Oncol. 2011. PMID: 21458091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

108 results

Search Page

Filters